Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126303891 | 12630389 | 1 | I | 20160726 | 20160808 | 20160808 | EXP | JP-TEVA-682388ISR | TEVA | OHE M, HASHINO S. SUCCESSFUL TREATMENT OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA WITH CLARITHROMYCIN.BLOOD RESEARCH. 2016; 51(2):139-142. | 71.00 | YR | M | Y | 0.00000 | 20160808 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126303891 | 12630389 | 1 | PS | PREDNISOLONE. | PREDNISOLONE | 1 | 50 MG ON DAY 1 TO 5 | Y | 89081 | 50 | MG | ||||||||
| 126303891 | 12630389 | 2 | SS | VINCRISTINE | VINCRISTINE | 1 | 1.6 MG ON DAY 1 | U | 0 | 1.6 | MG | ||||||||
| 126303891 | 12630389 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 750 MG ON DAY 1 | U | 0 | 750 | MG | ||||||||
| 126303891 | 12630389 | 4 | SS | DOXORUBICIN | DOXORUBICIN | 1 | 50 MG ON DAY 1 | U | 0 | 50 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126303891 | 12630389 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126303891 | 12630389 | Leukopenia | |
| 126303891 | 12630389 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |